Excited about the power of Inception? We are too. Stay apprised of our progress through our published news bureau. 

Recent News

FEBRUARY 15, 2022

Stanford’s Carolyn Bertozzi awarded Wolf Prize in Chemistry

FEBRUARY 8, 2022

Scripps Research Professor Benjamin Cravatt awarded 2022 Wolf Prize in Chemistry

August 25, 2021

Lilly and Lycia Therapeutics Enter into Strategic Collaboration to Discover and Develop Novel Lysosomal Targeting Chimera (LYTAC) Degraders

December 10, 2020

Special report: Twenty extraordinary women blazing trails in biopharma R&D — Covid-19 and beyond

June 9, 2020

Versant Ventures Launches Lycia Therapeutics with $50 Million

June 2, 2020

Aduro Biotech and Chinook Therapeutics Announce Definitive Merger Agreement

May 6, 2020

Ventus Therapeutics Launches with $60 Million Series A

January 10, 2020

Chinook Therapeutics Obtains Worldwide Rights from AbbVie to Atrasentan with Plans to Develop for the Treatment of Kidney Diseases

December 19, 2019

Pipeline Therapeutics Completes $30 Million Series B Financing

August 22, 2019

Chinook therapeutics raises $65 million series a financing to advance precision medicines for kidney diseases

May 16, 2019

Tempest Therapeutics Starts Phase I/Ib Clinical Trial with First-in-Class PPAR Alpha Antagonist

December 17, 2018

Versant Ventures Raises $700 Million

October 31, 2018

Ophthotech Expands Innovative Retinal Disease Pipeline with Acquisition of Versant Ventures’ Inception 4

April 4, 2018

Inception Neuroscience Program Acquired by Roche

March 28, 2018

Tempest Therapeutics Closes $70 Million Series B Financing